LIDWINA POWERS: Open Payments
NPI 1124355623 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,354 in 32 payments from 10 companies in 2025. Trend: 2023 $336 · 2024 $866 · 2025 $1,354
Food & beverage: $1,354
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $475 |
| Novo Nordisk Inc | 3 | $192 |
| AstraZeneca Pharmaceuticals LP | 3 | $179 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $179 |
| Amgen Inc. | 5 | $135 |
| Axsome Therapeutics, Inc. | 1 | $94 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Hologic Sales and Service, LLC | 1 | $24 |
| Insulet Corporation | 1 | $23 |
Products named: UBRELVY, CAPLYTA, QULIPTA, EVENITY, VRAYLAR, Wegovy, BREZTRI, Auvelity.
Industry payments across AR — which companies pay providers there.
